Robert M Paris

Summary

Affiliation: Armed Forces Research Institute of Medical Sciences
Country: Thailand

Publications

  1. ncbi HLA class I serotypes and cytotoxic T-lymphocyte responses among human immunodeficiency virus-1-uninfected Thai volunteers immunized with ALVAC-HIV in combination with monomeric gp120 or oligomeric gp160 protein boosting
    R Paris
    Department of Retrovirology, U S Army Medical Component, Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand
    Tissue Antigens 64:251-6. 2004
  2. ncbi Prime-boost immunization with poxvirus or adenovirus vectors as a strategy to develop a protective vaccine for HIV-1
    Robert M Paris
    US Military HIV Research Program MHRP, Department of Retrovirology, Armed Forces Research Institute of Medical Sciences, 315 6 Rajvithi Road, Bangkok, 10400, Thailand
    Expert Rev Vaccines 9:1055-69. 2010
  3. ncbi A phase 1/2 comparative vaccine trial of the safety and immunogenicity of a CRF01_AE (subtype E) candidate vaccine: ALVAC-HIV (vCP1521) prime with oligomeric gp160 (92TH023/LAI-DID) or bivalent gp120 (CM235/SF2) boost
    Prasert Thongcharoen
    Department of Microbiology, Faculty of Medicine, Siriraj Hospital, Bangkok, Thailand
    J Acquir Immune Defic Syndr 46:48-55. 2007
  4. ncbi The Thai phase III trial (RV144) vaccine regimen induces T cell responses that preferentially target epitopes within the V2 region of HIV-1 envelope
    Mark S de Souza
    U S Military HIV Research Program U S Army Medical Component, Armed Forces Research Institute of Medical Sciences, Bangkok 10400, Thailand
    J Immunol 188:5166-76. 2012
  5. ncbi Changes in HIV prevalence among young Thai men as defined by hepatitis C co-infection as a marker for mode of transmission
    Penprapa Chanbancherd
    Army Institute of Pathology, Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand
    AIDS 18:2339-41. 2004
  6. ncbi Antibody-dependent cell-mediated cytotoxic responses in participants enrolled in a phase I/II ALVAC-HIV/AIDSVAX B/E prime-boost HIV-1 vaccine trial in Thailand
    Chitraporn Karnasuta
    Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand
    Vaccine 23:2522-9. 2005
  7. ncbi Two Unique Recombinant Forms Identified in Incident HIV Type 1 Infections in Thai Blood Donors
    Wiriya Rutvisuttinunt
    1 Department of Retrovirology, Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand
    AIDS Res Hum Retroviruses 28:1703-11. 2012
  8. ncbi Use of dried blood spots for HIV-1 genotyping in Southeast Asia: Thailand experience
    Wiriya Rutvisuttinunt
    Department of Retrovirology, Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand
    Southeast Asian J Trop Med Public Health 43:333-9. 2012
  9. ncbi Functional variation of HIV-1 Rev Response Element in a longitudinally studied cohort
    Angsana Phuphuakrat
    Department of Microbiology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
    J Med Virol 75:367-73. 2005
  10. ncbi High frequency of HIV-1 and hepatitis C co-infection among young Thai men: evidence for a changing pattern of HIV transmission in Thailand
    Penprapa Chanbancherd
    Army Institute of Pathology, Bangkok, Thailand
    Southeast Asian J Trop Med Public Health 34:580-2. 2003

Collaborators

Detail Information

Publications10

  1. ncbi HLA class I serotypes and cytotoxic T-lymphocyte responses among human immunodeficiency virus-1-uninfected Thai volunteers immunized with ALVAC-HIV in combination with monomeric gp120 or oligomeric gp160 protein boosting
    R Paris
    Department of Retrovirology, U S Army Medical Component, Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand
    Tissue Antigens 64:251-6. 2004
    ..These results strengthen the importance of assessing HLA class I distributions in conjunction with studies of vaccines designed to elicit cellular immunity in different populations...
  2. ncbi Prime-boost immunization with poxvirus or adenovirus vectors as a strategy to develop a protective vaccine for HIV-1
    Robert M Paris
    US Military HIV Research Program MHRP, Department of Retrovirology, Armed Forces Research Institute of Medical Sciences, 315 6 Rajvithi Road, Bangkok, 10400, Thailand
    Expert Rev Vaccines 9:1055-69. 2010
    ....
  3. ncbi A phase 1/2 comparative vaccine trial of the safety and immunogenicity of a CRF01_AE (subtype E) candidate vaccine: ALVAC-HIV (vCP1521) prime with oligomeric gp160 (92TH023/LAI-DID) or bivalent gp120 (CM235/SF2) boost
    Prasert Thongcharoen
    Department of Microbiology, Faculty of Medicine, Siriraj Hospital, Bangkok, Thailand
    J Acquir Immune Defic Syndr 46:48-55. 2007
    ..A prime-boost HIV-1 vaccine trial assessing safety and immunogenicity was conducted in Thailand as part of an evaluation of candidate regimens for a phase 3 efficacy trial...
  4. ncbi The Thai phase III trial (RV144) vaccine regimen induces T cell responses that preferentially target epitopes within the V2 region of HIV-1 envelope
    Mark S de Souza
    U S Military HIV Research Program U S Army Medical Component, Armed Forces Research Institute of Medical Sciences, Bangkok 10400, Thailand
    J Immunol 188:5166-76. 2012
    ..Although the RV144 T cell responses were modest in frequency compared with humoral immune responses, the CD4(+) T cell response was directed to HIV-1 Env and more particularly the V2 region...
  5. ncbi Changes in HIV prevalence among young Thai men as defined by hepatitis C co-infection as a marker for mode of transmission
    Penprapa Chanbancherd
    Army Institute of Pathology, Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand
    AIDS 18:2339-41. 2004
    ..93-0.46%). This suggests that HIV-1 infection associated with parenteral transmission has been stable despite a dramatic reduction in the sexual transmission of HIV-1...
  6. ncbi Antibody-dependent cell-mediated cytotoxic responses in participants enrolled in a phase I/II ALVAC-HIV/AIDSVAX B/E prime-boost HIV-1 vaccine trial in Thailand
    Chitraporn Karnasuta
    Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand
    Vaccine 23:2522-9. 2005
    ..The results demonstrate that this HIV vaccine is a potent inducer of ADCC activity and may be an additional protection of this prime-boost vaccine in preventing HIV disease...
  7. ncbi Two Unique Recombinant Forms Identified in Incident HIV Type 1 Infections in Thai Blood Donors
    Wiriya Rutvisuttinunt
    1 Department of Retrovirology, Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand
    AIDS Res Hum Retroviruses 28:1703-11. 2012
    ..This study found two unique CRF01B recombinants circulating in 10 recent HIV-1-positive subjects from a blood donor population in Thailand...
  8. ncbi Use of dried blood spots for HIV-1 genotyping in Southeast Asia: Thailand experience
    Wiriya Rutvisuttinunt
    Department of Retrovirology, Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand
    Southeast Asian J Trop Med Public Health 43:333-9. 2012
    ..CRF01_AE was the predominant subtype identified using plasma samples (51/62) and DBS (24/27). There was no discordance in subtype designations between plasma and DBS...
  9. ncbi Functional variation of HIV-1 Rev Response Element in a longitudinally studied cohort
    Angsana Phuphuakrat
    Department of Microbiology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
    J Med Virol 75:367-73. 2005
    ..These data suggest that RRE heterogeneity may be important in viral pathogenesis and disease progression...
  10. ncbi High frequency of HIV-1 and hepatitis C co-infection among young Thai men: evidence for a changing pattern of HIV transmission in Thailand
    Penprapa Chanbancherd
    Army Institute of Pathology, Bangkok, Thailand
    Southeast Asian J Trop Med Public Health 34:580-2. 2003
    ..Antibody to HCV was present in 49.5% of HIV-infected men and 2.2% among uninfected men. These data suggest that a significant number of HIV infections among young men in Thailand may be associated with injection drug use...